The COVID-19 crisis has affected global economies in the past two years. At the end of 2021, a new coronavirus variant - Omicron took the world by storm and lead to more COVID-19 cases and can spread the virus to others, even if they are vaccinated or don’t have symptoms. However, according to data, Omicron leads to low fatality due to more vaccination rates. Scientists even make a forecast that SARS-CoV-2 will become a common virus as influenza and coronavirus and permanently reshape our world as it continues to unfold.

To all the incredible ladies and women in the world: Happy International Women's Day 2022!

March 4, 2022 is the 5th International International HPV Awareness Day to empower individuals and society to take effective action to reduce the harm caused by HPV.

As one of the listed Covid-19 antigen rapid test kits that are recommended and authorized for use by the Ministry of Health, Brunei Darussalam, Bioperfectus SARS-CoV-2 Ag Rapid Test Kits were sent to Brunei in 3 batches.

Bioperfectus, one of the leading in-vitro diagnostics providers for infectious diseases, has partnered with FIND, the global alliance for diagnostics, to lift the COVID-19 self-testing capacity in low- and middle-income countries (LMICs).

Bioperfectus Nucleic Acid Extraction System SSNP-3000A arrived at Sierra Leone-China Friendship Biological Safety Laboratory (SLE-CHN Biosafety Lab) during the Chinese New Year Festival.

Aprovação de Mercado para o Autoteste de Covid-19 de Bioperfectus em Portugal

Approvazione di Bioperfectus autotest per l’antigene COVID-19 in Italia

Bioperfectus today solemnly announce that Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test) has been entered in the electronic registry of the Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Health Products, AEMPS).

Bioperfectus SARS-CoV-2 Antigen Self-Testing is now officially included in Austrian Certified SARS-CoV-2 Antigen Rapid Tests Listing.